Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention-Health Disparities Subcommittee (HDS), 64504-64505 [2013-25428]

Download as PDF 64504 Federal Register / Vol. 78, No. 209 / Tuesday, October 29, 2013 / Notices Contact Person for More Information: Theodore Katz, Designated Federal Official, NIOSH, CDC, 1600 Clifton Road NE., Mailstop E–20, Atlanta Georgia 30333, Telephone: (513) 533– 6800, Toll Free 1 (800) CDC–INFO, Email: ocas@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–25431 Filed 10–28–13; 8:45 am] BILLING CODE 4163–18–P Centers for Disease Control and Prevention mstockstill on DSK4VPTVN1PROD with NOTICES Safety and Occupational Health Study Section (SOHSS), National Institute for Occupational Safety and Health (NIOSH or Institute) Cancellation: This notice was published in the Federal Register on September 12, 2013, Volume 78, Number 177, Pages 56235–56236. Contact Person for More Information: Price Connor, Ph.D., NIOSH Health Scientist, CDC, 2400 Executive Parkway, Mailstop E–20, Atlanta, Georgia 30345, Telephone: (404)498–2511, Fax: (404)498–2571. This notice is published less than the required 15 days prior to the start of the announced meeting, in accordance with Section 102–3.150(b) of the GSA Final Rule (2001) that allows for exceptions to the meeting notification time requirement. Section 102–3.150(b) states the following: ‘‘In exceptional circumstances, the agency or an independent Presidential advisory committee may give less than 15 calendar days’ notice, provided that the reasons for doing so are included in the advisory committee meeting notice published in the Federal Register.’’ In this case, the agency is giving less than 15 days’ notice due to the recent furlough status of United States Federal Government, including the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, from October 1–16, 2013. 18:15 Oct 28, 2013 Jkt 232001 Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–25426 Filed 10–28–13; 8:45 am] Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–25430 Filed 10–28–13; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4163–18–P Centers for Disease Control and Prevention (CDC) DEPARTMENT OF HEALTH AND HUMAN SERVICES Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention—Health Disparities Subcommittee (HDS) Centers for Disease Control and Prevention Advisory Committee on Breast Cancer in Young Women (ACBCYW) DEPARTMENT OF HEALTH AND HUMAN SERVICES VerDate Mar<15>2010 The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Cancellation: This notice was published in the Federal Register on September 18, 2013, Volume 78, Number 181, page 57391. The meeting previously scheduled to convene on October 31, 2013, has been cancelled. Contact Person for More Information: Temeika L. Fairley, Ph.D., Designated Federal Official, Office of the Director, Division of Cancer Prevention and Control, CDC, 5770 Buford Hwy NE., Mail Stop F–70, Atlanta, Georgia 30341, Telephone: (770) 488–4518, Fax: (770) 488–4760, Email: tfairley@cdc.gov. This notice is published less than the required 15 days prior to the start of the announced meeting, in accordance with Section 102–3.150(b) of the GSA Final Rule (2001) that allows for exceptions to the meeting notification time requirement. Section 102–3.150(b) states the following: ‘‘In exceptional circumstances, the agency or an independent Presidential advisory committee may give less than 15 calendar days’ notice, provided that the reasons for doing so are included in the advisory committee meeting notice published in the Federal Register.’’ In this case, the agency is giving less than 15 days’ notice due to the recent furlough status of United States Federal Government, including the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, from October 1–16, 2013. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 Notice of Cancellatiion: This notice was published in the Federal Register on October 22, 2013, Volume 78, Number 204, page 62635. The meeting previously scheduled to convene on October 28, 2013 has been cancelled. Contact Person for More Information: Leandris Liburd, Ph.D., M.P.H., M.A., Designated Federal Officer, Health Disparities Subcommittee, Advisory Committee to the Director, CDC, 1600 Clifton Road, NE., M/S K–77, Atlanta, GA 30333; Telephone (770) 488–8200, Email: LEL1@cdc.gov. This notice is published less than the required 15 days prior to the start of the announced meeting, in accordance with Section 102–3.150(b) of the GSA Final Rule (2001) that allows for exceptions to the meeting notification time requirement. Section 102–3.150(b) states the following: ‘‘In exceptional circumstances, the agency or an independent Presidential advisory committee may give less than 15 calendar days’ notice, provided that the reasons for doing so are included in the advisory committee meeting notice published in the Federal Register.’’ In this case, the agency is giving less than 15 days’ notice due to the recent furlough status of United States Federal Government, including the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, from October 1–16, 2013. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and E:\FR\FM\29OCN1.SGM 29OCN1 Federal Register / Vol. 78, No. 209 / Tuesday, October 29, 2013 / Notices Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–25428 Filed 10–28–13; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, National Center for Injury Prevention and Control, (BSC, NCIPC) mstockstill on DSK4VPTVN1PROD with NOTICES In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces, the following meeting of the aforementioned committee: Time and Date: 8:30 a.m.–4:30 p.m. Eastern Time, November 15, 2013. Place: Teleconference. Status: The meeting is open to the public; the toll free dial in number is 1–877–937– 9818 and the passcode is 7551384. Purpose: The board makes recommendations regarding policies, strategies, objectives, and priorities, and reviews progress toward injury prevention goals and provides evidence in injury prevention-related research and programs. The board provides advice on the appropriate balance of intramural and extramural research, and provides advice on the structure, progress and performance of intramural programs. The Board of Scientific Counselors is also designed to provide guidance on extramural scientific program matters, including the: (1) Review of extramural research concepts for funding opportunity announcements; (2) conduct of Secondary Peer Review of extramural research grants, cooperative agreements, and contracts applications received in response to the funding opportunity announcements as it relates to the Center’s programmatic balance and mission; (3) submission of secondary review recommendations to the Center Director of applications to be considered for funding support; (4) review of research portfolios, and (5) review of program proposals. The board shall provide guidance on the National Center of Injury Prevention and Control’s programs and research activities by conducting scientific peer review of intramural research and programs within the National Center for Injury Prevention and Control; by ensuring adherence to Office of Management and Budget requirements for intramural peer review; and by monitoring the overall direction, focus, and success of the National Center for Injury Prevention and Control. Matters to be Discussed: The BSC, NCIPC will discuss the recommendations provided by the expert panel on the Health VerDate Mar<15>2010 18:15 Oct 28, 2013 Jkt 232001 Communication Portfolio Review that has been conducted and to discuss research strategies needed to guide the Center’s focus. The BSC members will also discuss potential topics for the upcoming Portfolio Review. There will be 15 minutes allotted for public comments at the end of the open session. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Gwendolyn H. Cattledge, Ph.D., M.S.E.H., Designated Federal Official, NCIPC, CDC, 4770 Buford Highway NE., Mailstop F–63, Atlanta, Georgia 30341, Telephone: (770) 488–1430. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–25427 Filed 10–28–13; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2013–N–0001] Request for Nominations for Voting Members on a Public Advisory Committee; Tobacco Products Scientific Advisory Committee AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is requesting nominations for voting members to serve on the Tobacco Products Scientific Advisory Committee, Office of Science, Center for Tobacco Products. FDA seeks to include the views of women and men, members of all racial and ethnic groups, and individuals with and without disabilities on its advisory committees and, therefore, encourages nominations of appropriately qualified candidates from these groups. DATES: Nominations received on or before December 30, 2013, will be given first consideration for membership on the Tobacco Products Scientific Advisory Committee. Nominations received after December 30, 2013, will be considered for nomination to the committee as later vacancies occur. ADDRESSES: All nominations for membership should be sent electronically to cv@oc.fda.gov or by SUMMARY: PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 64505 mail to Advisory Committee Oversight and Management Staff, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 5103, Silver Spring, MD 20993–0002. FOR FURTHER INFORMATION CONTACT: Regarding all nomination questions for membership, the primary contact is: Caryn Cohen, Office of Science, Center for Tobacco Products, Food and Drug Administration, 9200 Corporate Blvd., Rockville, MD 20850, 1–877–287–1373 (choose Option 5), FAX: 240–276–3655, email: TPSAC@fda.hhs.gov. Information about becoming a member on an FDA advisory committee can also be obtained by visiting FDA’s Web site by using the following link: http://www.fda.gov/Advisory Committees/default.htm. SUPPLEMENTARY INFORMATION: FDA is requesting nominations for voting members on the Tobacco Products Scientific Advisory Committee. Elsewhere in this issue of the Federal Register, FDA is publishing a separate document announcing the Request for Nominations for Nonvoting Industry Representatives on the Tobacco Products Scientific Advisory Committee. I. General Description of the Committee Duties The Tobacco Products Scientific Advisory Committee advises the Commissioner or designee in discharging responsibilities as they relate to the regulation of tobacco products. The Committee reviews and evaluates safety, dependence, and health issues relating to tobacco products and provides appropriate advice, information, and recommendations to the Commissioner of Food and Drugs. II. Criteria for Voting Members The Committee shall consist of 12 members including the Chair. Members and the Chair are selected by the Commissioner or designee from among individuals knowledgeable in the fields of medicine, medical ethics, science, or technology involving the manufacture, evaluation, or use of tobacco products. Members will be invited to serve for overlapping terms of up to 4 years. Almost all non-Federal members of this committee serve as Special Government Employees. The Committee shall include nine technically qualified voting members, selected by the Commissioner or designee. The nine voting members shall be physicians, dentists, scientists, or health care professionals practicing in the area of oncology, pulmonology, cardiology, E:\FR\FM\29OCN1.SGM 29OCN1

Agencies

[Federal Register Volume 78, Number 209 (Tuesday, October 29, 2013)]
[Notices]
[Pages 64504-64505]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-25428]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention (CDC)


Advisory Committee to the Director (ACD), Centers for Disease 
Control and Prevention--Health Disparities Subcommittee (HDS)

    Notice of Cancellatiion: This notice was published in the Federal 
Register on October 22, 2013, Volume 78, Number 204, page 62635. The 
meeting previously scheduled to convene on October 28, 2013 has been 
cancelled.
    Contact Person for More Information: Leandris Liburd, Ph.D., 
M.P.H., M.A., Designated Federal Officer, Health Disparities 
Subcommittee, Advisory Committee to the Director, CDC, 1600 Clifton 
Road, NE., M/S K-77, Atlanta, GA 30333; Telephone (770) 488-8200, 
Email: LEL1@cdc.gov.
    This notice is published less than the required 15 days prior to 
the start of the announced meeting, in accordance with Section 102-
3.150(b) of the GSA Final Rule (2001) that allows for exceptions to the 
meeting notification time requirement. Section 102-3.150(b) states the 
following: ``In exceptional circumstances, the agency or an independent 
Presidential advisory committee may give less than 15 calendar days' 
notice, provided that the reasons for doing so are included in the 
advisory committee meeting notice published in the Federal Register.''
    In this case, the agency is giving less than 15 days' notice due to 
the recent furlough status of United States Federal Government, 
including the U.S. Department of Health and Human Services, Centers for 
Disease Control and Prevention, from October 1-16, 2013.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and

[[Page 64505]]

Prevention and the Agency for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2013-25428 Filed 10-28-13; 8:45 am]
BILLING CODE 4163-18-P